OFF-LABEL USES OF ANTICANCER DRUGS

被引:3
作者
ABELOFF, MD
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1992年 / 267卷 / 18期
关键词
D O I
10.1001/jama.267.18.2473
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2473 / 2474
页数:2
相关论文
共 2 条
[1]   REIMBURSEMENT POLICIES CONSTRAIN THE PRACTICE OF ONCOLOGY [J].
LAETZ, T ;
SILBERMAN, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :2996-2999
[2]   OFF-LABEL DRUG-USE FOR CANCER-THERAPY AND NATIONAL-HEALTH CARE PRIORITIES [J].
MOERTEL, CG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :3031-3032